FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1545-1552 November 23, 2000 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Despite remarkable social changes in the United States during the past century, issues related to race and ethnic background continue to permeate public discourse regarding health care.^1,2 The influence of race on the delivery of care for end-stage renal disease remains especially controversial because of two seemingly unrelated factors. First, the incidence of kidney failure among black Americans is disproportionately high, resulting in the demographic anomaly of black overrepresentation in the population with end-stage renal disease. Second, passage of the Social Security Amendments of 1972 entitled virtually all people in the United States with end-stage renal disease to Medicare-funded dialysis . . . [Full Text of this Article]

End-Stage Renal Disease in Black Americans

Therapy for End-Stage Renal Disease in Black Americans

Outcome of Renal Transplantation in Black Americans

Nonimmunologic Variables

Immunologic Variables

Integrating Immunologic and Nonimmunologic Causes of Graft Loss

Conclusions

Source Information

From the Department of Surgery, Division of Transplantation (C.J.Y., R.S.G.), and the Department of Medicine, Division of Nephrology (R.S.G.), University of Alabama at Birmingham, Birmingham.

Address reprint requests to Dr. Gaston at the Division of Nephrology, 625 THT, University of Alabama at Birmingham, 1530 3rd Ave. S., Birmingham, AL 35294-0006, or at rgaston@nrtc.dom.uab.edu.

References

This article has been cited by other articles:

• Locke, J. E., Warren, D. S., Dominici, F., Cameron, A. M., Leffell, M. S., McRann, D. A., Melancon, J. K., Segev, D. L., Simpkins, C. E., Singer, A. L., Zachary, A. A., Montgomery, R. A. (2008). Donor Ethnicity Influences Outcomes following Deceased-Donor Kidney Transplantation in Black Recipients. J. Am. Soc. Nephrol. 19: 2011-2019 [Abstract] [Full Text]  
• Wolf, M., Betancourt, J., Chang, Y., Shah, A., Teng, M., Tamez, H., Gutierrez, O., Camargo, C. A. Jr., Melamed, M., Norris, K., Stampfer, M. J., Powe, N. R., Thadhani, R. (2008). Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients. J. Am. Soc. Nephrol. 19: 1379-1388 [Abstract] [Full Text]  
• Criner, G. J. (2007). Framing the Forum: Medical Ethics in Large-Scale, Interventional Respiratory Clinical Trials. Proc Am Thorac Soc 4: 171-175 [Abstract] [Full Text]  
• Augustine, J. J., Poggio, E. D., Clemente, M., Aeder, M. I., Bodziak, K. A., Schulak, J. A., Heeger, P. S., Hricik, D. E. (2007). Hemodialysis Vintage, Black Ethnicity, and Pretransplantation Antidonor Cellular Immunity in Kidney Transplant Recipients. J. Am. Soc. Nephrol. 18: 1602-1606 [Abstract] [Full Text]  
• Grubbs, V. (2007). Good For Harvest, Bad For Planting. Health Aff (Millwood) 26: 232-237 [Full Text]  
• Poggio, E. D., Clemente, M., Hricik, D. E., Heeger, P. S. (2006). Panel of Reactive T Cells as a Measurement of Primed Cellular Alloimmunity in Kidney Transplant Candidates. J. Am. Soc. Nephrol. 17: 564-572 [Abstract] [Full Text]  
• Weng, F. L., Israni, A. K., Joffe, M. M., Hoy, T., Gaughan, C. A., Newman, M., Abrams, J. D., Kamoun, M., Rosas, S. E., Mange, K. C., Strom, B. L., Brayman, K. L., Feldman, H. I. (2005). Race and Electronically Measured Adherence to Immunosuppressive Medications after Deceased Donor Renal Transplantation. J. Am. Soc. Nephrol. 16: 1839-1848 [Abstract] [Full Text]  
• Magee, C. C., Pascual, M. (2004). Update in Renal Transplantation. Arch Intern Med 164: 1373-1388 [Abstract] [Full Text]  
• Higgins, R. S.D. (2003). Understanding disparities in outcomes in cardiovascular medicine and thoracic oncology in African-American patients. Ann. Thorac. Surg. 76: S1346-1347 [Full Text]  
• Shorr, A. F., Davies, D. B., Nathan, S. D. (2003). Predicting Mortality in Patients With Sarcoidosis Awaiting Lung Transplantation. Chest 124: 922-928 [Abstract] [Full Text]  
• Kales, H. C., Kamholz, B. A., Visnic, S. G., Blow, F. C. (2003). Recorded Delirium in a National Sample of Elderly Inpatients: Potential Implications for Recognition. J Geriatr Psychiatry Neurol 16: 32-38 [Abstract]  
• Mahomed, N. N., Barrett, J. A., Katz, J. N., Phillips, C. B., Losina, E., Lew, R. A., Guadagnoli, E., Harris, W. H., Poss, R., Baron, J. A. (2003). Rates and Outcomes of Primary and Revision Total Hip Replacement in the United States Medicare Population. JBJS 85: 27-32 [Abstract] [Full Text]  
• Klassen, A. C., Hall, A. G., Saksvig, B., Curbow, B., Klassen, D. K. (2002). Relationship Between Patients' Perceptions of Disadvantage and Discrimination and Listing for Kidney Transplantation. Am. J. Public Health 92: 811-817 [Abstract] [Full Text]